Cancer patients undergoing chemotherapy or radiation often suffer from thrombocytopenia, which can lead to dangerous bleeding complications. TPO-RAs help stimulate the production of platelets, thereby reducing the risk of bleeding and allowing patients to continue with their cancer treatments without interruption. This can be particularly important in maintaining the efficacy of cancer therapy.
